Приказ основних података о документу

dc.creatorSokka, Tuulikki
dc.creatorKautiainen, Hannu
dc.creatorToloza, Sergio
dc.creatorMakinen, Heidi
dc.creatorVerstappen, Suzan M. M.
dc.creatorHetland, Merete Lund
dc.creatorNaranjo, Antonio
dc.creatorBaecklund, Eva
dc.creatorHerborn, Gertraud
dc.creatorRau, Rolf
dc.creatorCazzato, Massimiliano
dc.creatorGossec, Laure
dc.creatorSkakic, Vlado
dc.creatorGogus, Feride
dc.creatorSierakowski, Stanislaw
dc.creatorBresnihan, Barry
dc.creatorTaylor, Peter
dc.creatorMcClinton, Catherine
dc.creatorPincus, Theodore
dc.creatorthe QUEST-RA Grp
dc.date.accessioned2018-03-01T20:13:23Z
dc.date.available2018-03-01T20:13:23Z
dc.date.issued2007
dc.identifier.issn0003-4967
dc.identifier.urihttps://vinar.vin.bg.ac.rs/handle/123456789/3303
dc.description.abstractObjective: To conduct a cross- sectional review of non- selected consecutive outpatients with rheumatoid arthritis ( RA) as part of standard clinical care in 15 countries for an overview of the characteristics of patients with RA. Methods: The review included current disease activity using data from clinical assessment and a patient self-report questionnaire, which was translated into each language. Data on demographic, disease and treatment- related variables were collected and analysed using descriptive statistics. Variation in disease activity on DAS28 ( disease activity score on 28- joint count) within and between countries was graphically analysed. A median regression model was applied to analyse differences in disease activity between countries. Results: Between January 2005 and October 2006, the QUEST- RA ( Quantitative Patient Questionnaires in Standard Monitoring of Patients with Rheumatoid Arthritis) project included 4363 patients from 48 sites in 15 countries; 78% were female,. GT 90% Caucasian, mean age was 57 years and mean disease duration was 11.5 years. More than 80% of patients had been treated with methotrexate in all but three countries. Overall, patients had an active disease with a median DAS28 of 4.0, with a significant variation between countries ( p LT 0.001). Among 42 sites with GT 50 patients included, low disease activity of DAS28 LT = 3.2 was found in the majority of patients in seven sites in five countries; in eight sites in five other countries, GT 50% of patients had high disease activity of DAS28 GT 5.1. Conclusions: This international multicentre cross- sectional database provides an overview of clinical status and treatments of patients with RA in standard clinical care in 2005 - 6 including countries that are infrequently involved in clinical research projects.en
dc.rightsopenAccessen
dc.sourceAnnals of the Rheumatic Diseasesen
dc.titleQUEST-RA: quantitative clinical assessment of patients with rheumatoid arthritis seen in standard rheumatology care in 15 countriesen
dc.typearticleen
dcterms.abstractКаутиаинен, Ханну; Толоза, Сергио; Макинен, Хеиди; Верстаппен, Сузан М. М.; Хетланд, Мерете Лунд; Нарањо, Aнтонио; Баецклунд, Ева; Херборн, Гертрауд; Рау, Ролф; Цаззато, Массимилиано; Госсец, Лауре; Скакиц, Владо; Гогус, Фериде; Сиеракоwски, Станислаw; Бреснихан, Баррy; Таyлор, Петер; МцЦлинтон, Цатхерине; Пинцус, Тхеодоре; тхе QУЕСТ-РA Грп; Сокка, Тууликки;
dc.citation.volume66
dc.citation.issue11
dc.citation.spage1491
dc.citation.epage1496
dc.identifier.wos000250147900015
dc.identifier.doi10.1136/ard.2006.069252
dc.citation.rankM21a
dc.identifier.pmid17412740
dc.identifier.scopus2-s2.0-34347388745


Документи

ДатотекеВеличинаФорматПреглед

Уз овај запис нема датотека.

Овај документ се појављује у следећим колекцијама

Приказ основних података о документу